发明名称 CELL ABLATION USING TRANS-SPLICING RIBOZYMES
摘要 The design of new ribozymes capable of self-catalyzed trans-splicing which are based upon the catalytic core of a Group I intron are described. Using this design, it is possible to construct ribozymes capable of efficiently splicing a new 3' exon sequence into any chosen target RNA sequence in a highly precise manner. A method of cell ablation is also described that provides a toxic product to a host cell in vivo in a targetted, regulated manner utilizing novel trans-splicing ribozymes of the invention. Inactive pro-ribozyme forms are also described.
申请公布号 WO9213089(A1) 申请公布日期 1992.08.06
申请号 WO1992US00277 申请日期 1992.01.16
申请人 THE GENERAL HOSPITAL CORPORATION;THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE 发明人 HASELOFF, JAMES;BRAND, ANDREA;PERRIMON, NORBERT;GOODMAN, HOWARD, M.
分类号 C12N1/21;A61K38/00;C07K7/06;C12N;C12N5/10;C12N7/00;C12N9/10;C12N15/09;C12N15/113;C12N15/52;C12N15/66;C12N15/82;C12N15/85;C12N15/90 主分类号 C12N1/21
代理机构 代理人
主权项
地址